Skip to main content
SpringerLink
Log in

Management of Locally Advanced Thyroid Cancer

  • Chapter
  • First Online:
Evidence-Based Endocrine Surgery

  • 646 Accesses

Abstract

Cancer staging allows patients to be stratified based on aggressiveness of their disease and provides important prognostic information to both the patient and clinician. The tumor-nodal-metastasis (TNM) system from the American Joint Committee on Cancer (AJCC) is the most commonly used staging system for many cancers, including thyroid cancer, and has been shown to predict differentiated thyroid cancer-related death [1]. While most patients with thyroid carcinoma have well-differentiated tumors that have an excellent prognosis, there are certain characteristics that carry a worse prognosis, including older age, larger primary tumor size, aggressive tumor histology, extrathyroidal tumor extension (ETE), and distant metastasis [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Tanase K, Thies E-D, Mäder U, Reiners C, Verburg FA. The TNM system (version 7) is the most accurate staging system for the prediction of loss of life expectancy in differentiated thyroid cancer. Clin Endocrinol (Oxf). 2015;[Epub ahead of print].

    Google Scholar 

  2. Price DL, Wong RJ, Randolph GW. Invasive thyroid cancer: management of the trachea and esophagus. Otolaryngol Clin N Am. 2008;41(6):1155–68. ix–x

    Article  Google Scholar 

  3. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050–7. discussion 1057–8

    CAS  PubMed  Google Scholar 

  4. Ibrahimpasic T, Nixon IJ, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, et al. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer—is there a need for radioactive iodine therapy? Surgery. 2012;152(6):1096–105.

    Article  Google Scholar 

  5. Patel KN, Shaha AR. Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 2005;13(2):112–6.

    Article  Google Scholar 

  6. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170(5):467–70.

    Article  CAS  Google Scholar 

  7. McCaffrey TV, Bergstralh EJ, Hay ID. Locally invasive papillary thyroid carcinoma: 1940–1990. Head Neck. 1994;16(2):165–72.

    Article  CAS  Google Scholar 

  8. Ark N, Zemo S, Nolen D, Holsinger FC, Weber RS. Management of locally invasive well-differentiated thyroid cancer. Surg Oncol Clin N Am. 2008;17(1):145–55. ix

    Article  Google Scholar 

  9. Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 2017;27(6):751–6.

    Article  Google Scholar 

  10. Nishida T, Nakao K, Hamaji M, Kamiike W, Kurozumi K, Matsuda H. Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer. Ann Surg. 1997;226(1):85–91.

    Article  CAS  Google Scholar 

  11. Chiang F-Y, Wang L-F, Huang Y-F, Lee K-W, Kuo W-R. Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve. Surgery. 2005;137(3):342–7.

    Article  Google Scholar 

  12. Falk SA, McCaffrey TV. Management of the recurrent laryngeal nerve in suspected and proven thyroid cancer. Otolaryngol Head Neck Surg. 1995;113(1):42–8.

    Article  CAS  Google Scholar 

  13. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82(2):375–88.

    Article  CAS  Google Scholar 

  14. Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope. 2006;116(9):1657–61.

    Article  Google Scholar 

  15. Miyauchi A, Inoue H, Tomoda C, Fukushima M, Kihara M, Higashiyama T, et al. Improvement in phonation after reconstruction of the recurrent laryngeal nerve in patients with thyroid cancer invading the nerve. Surgery. 2009;146(6):1056–62.

    Article  Google Scholar 

  16. Czaja JM, McCaffrey TV. The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123(5):484–90.

    Article  CAS  Google Scholar 

  17. McCaffrey JC. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology. Laryngoscope. 2006;116(1):1–11.

    Article  Google Scholar 

  18. McCaffrey JC. Evaluation and treatment of aerodigestive tract invasion by well-differentiated thyroid carcinoma. Cancer Control. 2000;7(3):246–52.

    Article  CAS  Google Scholar 

  19. An S-Y, Kim KH. Surgical management of locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 2010;18(2):119–23.

    Article  Google Scholar 

  20. McCaffrey TV, Lipton RJ. Thyroid carcinoma invading the upper aerodigestive system. Laryngoscope. 1990;100(8):824–30.

    Article  Google Scholar 

  21. Donnelly MJ, Timon CI, McShane DP. The role of total laryngectomy in the management of intraluminal upper airway invasion by well-differentiated thyroid carcinoma. Ear Nose Throat J. 1994;73(9):659–62.

    CAS  PubMed  Google Scholar 

  22. Friedman M, Danielzadeh JA, Caldarelli DD. Treatment of patients with carcinoma of the thyroid invading the airway. Arch Otolaryngol Head Neck Surg. 1994;120(12):1377–81.

    Article  CAS  Google Scholar 

  23. Shin DH, Mark EJ, Suen HC, Grillo HC. Pathologic staging of papillary carcinoma of the thyroid with airway invasion based on the anatomic manner of extension to the trachea: a clinicopathologic study based on 22 patients who underwent thyroidectomy and airway resection. Hum Pathol. 1993;24(8):866–70.

    Article  CAS  Google Scholar 

  24. Nishida T, Nakao K, Hamaji M. Differentiated thyroid carcinoma with airway invasion: indication for tracheal resection based on the extent of cancer invasion. J Thorac Cardiovasc Surg. 1997;114(1):84–92.

    Article  CAS  Google Scholar 

  25. Segal K, Shpitzer T, Hazan A, Bachar G, Marshak G, Popovtzer A. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome. Otolaryngol Head Neck Surg. 2006;134(5):819–22.

    Article  Google Scholar 

  26. Park CS, Suh KW, Min JS. Cartilage-shaving procedure for the control of tracheal cartilage invasion by thyroid carcinoma. Head Neck. 1993;15(4):289–91.

    Article  CAS  Google Scholar 

  27. Kasperbauer JL. Locally advanced thyroid carcinoma. Ann Otol Rhinol Laryngol. 2004;113(9):749–53.

    Article  Google Scholar 

  28. Gaissert HA, Honings J, Grillo HC, Donahue DM, Wain JC, Wright CD, et al. Segmental laryngotracheal and tracheal resection for invasive thyroid carcinoma. Ann Thorac Surg. 2007;83(6):1952–9.

    Article  Google Scholar 

  29. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid. 1998;8(9):737–44.

    Article  CAS  Google Scholar 

  30. McGriff NJ, Csako G, Gourgiotis L, Lori CG, Pucino F, Sarlis NJ. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med. 2002;34(7–8):554–64.

    Article  CAS  Google Scholar 

  31. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418–28.

    Article  CAS  Google Scholar 

  32. Mazzaferri EL. Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab. 1995;80(5):1485–7.

    Article  CAS  Google Scholar 

  33. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75(3):714–20.

    CAS  PubMed  Google Scholar 

  34. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer. 1985;55(9 Suppl):2062–71.

    Article  CAS  Google Scholar 

  35. Lee N, Tuttle M. The role of external beam radiotherapy in the treatment of papillary thyroid cancer. Endocr Relat Cancer. 2006;13(4):971–7.

    Article  Google Scholar 

  36. Kiess AP, Agrawal N, Brierley JD, Duvvuri U, Ferris RL, Genden E, et al. External-beam radiotherapy for differentiated thyroid cancer locoregional control: a statement of the American Head and Neck Society: external-beam RT for differentiated thyroid cancer. Head Neck. 2016;38(4):493–8.

    Article  Google Scholar 

  37. O’Connell ME, A’Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer. 1994;30A(6):733–9.

    Article  Google Scholar 

  38. Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer. 1996;77(1):172–80.

    Article  CAS  Google Scholar 

  39. Romesser PB, Sherman EJ, Shaha AR, Lian M, Wong RJ, Sabra M, et al. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer. J Surg Oncol. 2014;110(4):375–82.

    Article  Google Scholar 

  40. Ford D, Giridharan S, McConkey C, Hartley A, Brammer C, Watkinson JC, Glaholm J. External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol. 2003;15(6):337–41.

    Article  CAS  Google Scholar 

  41. Urbano TG, Clark CH, Hansen VN, Adams EJ, Miles EA, Mc Nair H, et al. Intensity modulated radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol. 2007;85(1):58–63.

    Article  Google Scholar 

  42. Sarlis NJ. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research. Curr Drug Targets Immune Endocr Metab Disord. 2001;1(2):103–15.

    Article  CAS  Google Scholar 

  43. Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015;372(7):621–30.

    Article  Google Scholar 

  44. Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014;384(9940):319–28.

    Article  CAS  Google Scholar 

  45. Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N Engl J Med. 2013;368(7):623–32.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Memorial Sloane Kettering Centre, New York, NY, USA

    Andrea R. Marcadis, Jennifer Cracchiolo & Ashok K. Shaha

Authors
  1. Andrea R. Marcadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Cracchiolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashok K. Shaha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok K. Shaha .

Editor information

Editors and Affiliations

  1. Division of Endocrine Surgery, National University Hospital, Singapore, Singapore

    Rajeev Parameswaran

  2. Department of Endocrine Surgery, SGPGI Hospital, Lucknow, India

    Amit Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marcadis, A.R., Cracchiolo, J., Shaha, A.K. (2018). Management of Locally Advanced Thyroid Cancer. In: Parameswaran, R., Agarwal, A. (eds) Evidence-Based Endocrine Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-10-1124-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1124-5_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1123-8

  • Online ISBN: 978-981-10-1124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation